[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU1687500A - Antihuman vegf monoclonal antibody - Google Patents

Antihuman vegf monoclonal antibody

Info

Publication number
AU1687500A
AU1687500A AU16875/00A AU1687500A AU1687500A AU 1687500 A AU1687500 A AU 1687500A AU 16875/00 A AU16875/00 A AU 16875/00A AU 1687500 A AU1687500 A AU 1687500A AU 1687500 A AU1687500 A AU 1687500A
Authority
AU
Australia
Prior art keywords
monoclonal antibody
vegf monoclonal
antihuman
antihuman vegf
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16875/00A
Inventor
Nobuo Hanai
Mikito Ito
Junji Kanazawa
Masabumi Shibuya
Kenya Shitara
Tatsuya Tamaoki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of AU1687500A publication Critical patent/AU1687500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU16875/00A 1998-12-16 1999-12-16 Antihuman vegf monoclonal antibody Abandoned AU1687500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10/357148 1998-12-16
JP35714898 1998-12-16
PCT/JP1999/007074 WO2000035956A1 (en) 1998-12-16 1999-12-16 Antihuman vegf monoclonal antibody

Publications (1)

Publication Number Publication Date
AU1687500A true AU1687500A (en) 2000-07-03

Family

ID=18452629

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16875/00A Abandoned AU1687500A (en) 1998-12-16 1999-12-16 Antihuman vegf monoclonal antibody

Country Status (2)

Country Link
AU (1) AU1687500A (en)
WO (1) WO2000035956A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2328893A1 (en) * 1998-05-20 1999-11-25 Kyowa Hakko Kogyo Co., Ltd. Vegf activity inhibitors
AR045563A1 (en) * 2003-09-10 2005-11-02 Warner Lambert Co ANTIBODIES DIRECTED TO M-CSF
TW200812615A (en) 2006-03-22 2008-03-16 Hoffmann La Roche Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2
PL2056874T3 (en) 2006-08-21 2013-02-28 Hoffmann La Roche Tumor therapy with an anti-vegf antibody
US20090162359A1 (en) 2007-12-21 2009-06-25 Christian Klein Bivalent, bispecific antibodies
US9266967B2 (en) 2007-12-21 2016-02-23 Hoffmann-La Roche, Inc. Bivalent, bispecific antibodies
US8268314B2 (en) 2008-10-08 2012-09-18 Hoffmann-La Roche Inc. Bispecific anti-VEGF/anti-ANG-2 antibodies
MX2011010159A (en) 2009-04-02 2011-10-17 Roche Glycart Ag Multispecific antibodies comprising full length antibodies and single chain fab fragments.
CA2757931C (en) 2009-04-07 2019-03-26 Roche Glycart Ag Trivalent, bispecific antibodies
US9676845B2 (en) 2009-06-16 2017-06-13 Hoffmann-La Roche, Inc. Bispecific antigen binding proteins
WO2011034605A2 (en) 2009-09-16 2011-03-24 Genentech, Inc. Coiled coil and/or tether containing protein complexes and uses thereof
TWI426920B (en) 2010-03-26 2014-02-21 Hoffmann La Roche Bispecific, bivalent anti-vegf/anti-ang-2 antibodies
TW201138821A (en) 2010-03-26 2011-11-16 Roche Glycart Ag Bispecific antibodies
TW201208703A (en) 2010-08-17 2012-03-01 Roche Glycart Ag Combination therapy of an afucosylated CD20 antibody with an anti-VEGF antibody
CN103068846B9 (en) 2010-08-24 2016-09-28 弗·哈夫曼-拉罗切有限公司 Bispecific antibodies comprising disulfide-stabilized Fv fragments
SG191153A1 (en) 2010-12-23 2013-07-31 Hoffmann La Roche Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
RU2013141078A (en) 2011-02-28 2015-04-10 Ф. Хоффманн-Ля Рош Аг SINGLE VALVE ANTI-BINDING PROTEINS
RU2607038C2 (en) 2011-02-28 2017-01-10 Ф. Хоффманн-Ля Рош Аг Antigen-binding proteins
WO2013119966A2 (en) 2012-02-10 2013-08-15 Genentech, Inc. Single-chain antibodies and other heteromultimers
EP2867254B1 (en) 2012-06-27 2017-10-25 F. Hoffmann-La Roche AG Method for making antibody fc-region conjugates comprising at least one binding entity that specifically binds to a target and uses thereof
BR112014032193A2 (en) 2012-06-27 2017-06-27 Hoffmann La Roche bispecific antibody production and combination determination methods, bispecific antibody, formulation and use of bispecific antibody
EP2872534B1 (en) 2012-07-13 2018-08-08 Roche Glycart AG Bispecific anti-vegf/anti-ang-2 antibodies and their use in the treatment of ocular vascular diseases
CN104341504B (en) 2013-08-06 2017-10-24 百奥泰生物科技(广州)有限公司 Bispecific antibody
CA2922912A1 (en) 2013-10-11 2015-04-16 F. Hoffmann-La Roche Ag Multispecific domain exchanged common variable light chain antibodies
EP3227332B1 (en) 2014-12-03 2019-11-06 F.Hoffmann-La Roche Ag Multispecific antibodies
JP2021508471A (en) 2017-12-29 2021-03-11 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ How to Improve VEGF Receptor Blocking Selectivity of Anti-VEGF Antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5730977A (en) * 1995-08-21 1998-03-24 Mitsui Toatsu Chemicals, Inc. Anti-VEGF human monoclonal antibody
JPH10245347A (en) * 1997-02-28 1998-09-14 Toagosei Co Ltd Agent for inhibiting restorage of body fluid

Also Published As

Publication number Publication date
WO2000035956A1 (en) 2000-06-22

Similar Documents

Publication Publication Date Title
AU1687500A (en) Antihuman vegf monoclonal antibody
AU4042195A (en) Anti-alphaV-integrin monoclonal antibody
DE69920897D1 (en) MONOCLONAL ANTIBODIES WITH REDUCED IMMUNIZABILITY
AU1462300A (en) Human pan-hcv human monoclonal antibodies
AU7863794A (en) Antihuman tyrosinase monoclonal antibody
IL128406A0 (en) Monoclonal antibodies
HUP0300841A3 (en) Agonist anti-trk-c monoclonal antibodies
EP1071458A4 (en) Humanized antibody and uses thereof
AU8432498A (en) Human-cd28 specific monoclonal antibodies for antigen non-specific activation oft-lymphocytes
AU2002220843A1 (en) Humanised antibodies and uses thereof
IL147517A0 (en) Monoclonal antibodies and immunoassay utilizing the same
AU6702998A (en) Anti-alphabeta3 humanized monoclonal antibodies
AU7072998A (en) Immunoassays using anti-allotypic monoclonal antibodies
AU1598801A (en) HGF-SF monoclonal antibody combinations
IL132139A0 (en) Anti-fas antibodies
AU5970198A (en) Anti-fas antibodies
AU2596397A (en) Monoclonal antibody that detects apoptotic antigen
GB9818915D0 (en) Antibodies
AU2001284899A1 (en) Methods and universal monoclonal antibody array
GB9828700D0 (en) Antibody
GB9718911D0 (en) Monoclonal antibodies
GB9819411D0 (en) Antibodies
EP1106701A4 (en) Monoclonal antibody against canine trypsin
AUPP259798A0 (en) Monoclonal antibody against hb-egf
AU2002217525A1 (en) Novel monoclonal antibody

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase